2017
DOI: 10.1016/j.ejso.2017.01.238
|View full text |Cite
|
Sign up to set email alerts
|

Radial scar of the breast: Is it possible to avoid surgery?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
15
0
5

Year Published

2017
2017
2020
2020

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 31 publications
(22 citation statements)
references
References 39 publications
2
15
0
5
Order By: Relevance
“…Several authors have reported a significant risk of missed associated carcinoma when RS/CSL is diagnosed on percutaneous biopsy . Others have suggested that percutaneous biopsies are reliable for excluding malignancy, especially when VALCBs are performed . This is mainly due to reports of heterogeneous series.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Several authors have reported a significant risk of missed associated carcinoma when RS/CSL is diagnosed on percutaneous biopsy . Others have suggested that percutaneous biopsies are reliable for excluding malignancy, especially when VALCBs are performed . This is mainly due to reports of heterogeneous series.…”
Section: Discussionmentioning
confidence: 99%
“…However, there are no published data based on homogeneous cohorts exclusively composed of RS/CSL cases diagnosed on VALCB. Moreover, knowledge on the predictive factors for surgical upgrade is lacking …”
Section: Introductionmentioning
confidence: 99%
“…Upgrade rates of RS to atypia or malignancy, however, range widely (0%‐40%) 7,8 . There has also been suggestion that the type of CNB impacts upgrade rates but the general conclusion reached from this research advises observation of patients with RS and no other atypia 4,9‐12 . These discrepancies suggest more research is necessary to fully elucidate the optimal treatment when RS are identified on CNB 5 …”
Section: Introductionmentioning
confidence: 83%
“…Of the 15 other studies, four studies: Nassar et al [ 18 ], Mooney et al [ 3 ], Rageth et al [ 2 ], and Ferreira et al [ 19 ] yielded comparatively high upgrade rates (10.5, 16.0, 10.9, 13.5%, respectively, average upgrade rate 12.6%, 25 of 198 total patients) to malignancy compared to the other 11 studies (average upgrade 1.4%, 12 of 887 patients). The exclusion criteria for first three studies were similar in that patients with any atypia observed with RS on CNB were excluded.…”
Section: Literature Reviewmentioning
confidence: 99%
“…Mooney et al excluded RS associated with any type of epithelial atypia and cases with known synchronous ipsilateral breast cancer [ 3 ]. Ferreria et al excluded patients with a simultaneous breast malignancy (invasive or in situ breast cancer) and also patients with a follow-up interval less than 12 months if surgery was not performed after an image-guided CNB [ 19 ]. Rageth et al did not specifically list exclusion criteria in their publication [ 2 ].…”
Section: Literature Reviewmentioning
confidence: 99%